| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
ACELYRIN, Inc.
13D
SLRN · 00445A100
|
5.1% |
4/30/2025
Event 4/29/2025
|
||||
| Madison Avenue International LP | 5.1% | |||||
| Madison Avenue Partners, LP | 5.1% | |||||
| EMAI Management, LLC | 5.1% | |||||
| Madison Avenue GP, LLC | 5.1% | |||||
| Caraway Jackson Investments LLC | 5.1% | |||||
| Eli Samaha | 5.1% | |||||
| Schedule 13G · 14 securities · passive | ||||||
|
STAAR SURGICAL CO ("Issuer")
13G/A
STAA · 852312305
|
9.7% |
11/16/2026
Event 9/30/2026
|
||||
| Madison Avenue International LP | 9.7% | |||||
| Madison Avenue Partners, LP | 9.7% | |||||
| EMAI Management, LLC | 9.7% | |||||
| Madison Avenue GP, LLC | 9.7% | |||||
| Caraway Jackson Investments LLC | 9.7% | |||||
| Eli Samaha | 9.7% | |||||
|
Theravance Biopharma, Inc.
13G/A
TBPH · G8807B106
|
0% |
11/16/2026
Event 9/23/2026
|
||||
| Madison Avenue International LP | 0% | |||||
| Madison Avenue Partners, LP | 0% | |||||
| EMAI Management, LLC | 0% | |||||
| Madison Avenue GP, LLC | 0% | |||||
| Caraway Jackson Investments LLC | 0% | |||||
| Eli Samaha | 0% | |||||
|
Ultragenyx Pharmaceutical Inc.
13G
RARE · 90400D108
|
6.4% |
10/20/2026
Event 10/13/2026
|
||||
| Madison Avenue International LP | 6.4% | |||||
| Madison Avenue Partners, LP | 6.4% | |||||
| EMAI Management, LLC | 6.4% | |||||
| Madison Avenue GP, LLC | 6.4% | |||||
| Caraway Jackson Investments LLC | 6.4% | |||||
| Eli Samaha | 6.4% | |||||
|
Graham Holdings Co
13G
GHC · 384637104
|
7.5% |
8/14/2026
Event 6/30/2026
|
||||
| Madison Avenue International LP | 7.5% | |||||
| Madison Avenue Partners, LP | 7.5% | |||||
| EMAI Management, LLC | 7.5% | |||||
| Madison Avenue GP, LLC | 7.5% | |||||
| Caraway Jackson Investments LLC | 7.5% | |||||
| Eli Samaha | 7.5% | |||||
|
Lakefront Biotherapeutics NV
13G
LKFT · 36315X101
|
5.5% |
6/23/2026
Event 6/15/2026
|
||||
| Madison Avenue International LP | 5.5% | |||||
| Madison Avenue Partners, LP | 5.5% | |||||
| EMAI Management, LLC | 5.5% | |||||
| Madison Avenue GP, LLC | 5.5% | |||||
| Caraway Jackson Investments LLC | 5.5% | |||||
| Eli Samaha | 5.5% | |||||
|
Magnera Corporation
13G/A
MAGN · 55939A107
|
4.4% |
5/15/2026
Event 3/31/2026
|
||||
| Madison Avenue International LP | 4.4% | |||||
| Madison Avenue Partners, LP | 4.4% | |||||
| EMAI Management, LLC | 4.4% | |||||
| Madison Avenue GP, LLC | 4.4% | |||||
| Caraway Jackson Investments LLC | 4.4% | |||||
| Eli Samaha | 4.4% | |||||
|
Indivior Pharmaceuticals, Inc.
13G/A
INDV · G4766E116
|
3.5% |
5/15/2026
Event 3/31/2026
|
||||
| Madison Avenue International LP | 3.5% | |||||
| Madison Avenue Partners, LP | 3.5% | |||||
| EMAI Management, LLC | 3.5% | |||||
| Madison Avenue GP, LLC | 3.5% | |||||
| Caraway Jackson Investments LLC | 3.5% | |||||
| Eli Samaha | 3.5% | |||||
|
Apartment Investment & Management Co
13G
AIV · 03748R747
|
8.6% |
3/4/2026
Event 2/26/2026
|
||||
| Madison Avenue International LP | 8.6% | |||||
| Madison Avenue Partners, LP | 8.6% | |||||
| EMAI Management, LLC | 8.6% | |||||
| Madison Avenue GP, LLC | 8.6% | |||||
| Caraway Jackson Investments LLC | 8.6% | |||||
| Eli Samaha | 8.6% | |||||
|
Keros Therapeutics, Inc.
13G/A
KROS · 492327101
|
2.7% |
2/17/2026
Event 12/31/2025
|
||||
| Madison Avenue International LP | 2.7% | |||||
| Madison Avenue Partners, LP | 2.7% | |||||
| EMAI Management, LLC | 2.7% | |||||
| Madison Avenue GP, LLC | 2.7% | |||||
| Caraway Jackson Investments LLC | 2.7% | |||||
| Eli Samaha | 2.7% | |||||
|
Veradigm Inc.
13G
MDRX · 01988P108
|
6.6% |
1/29/2026
Event 1/22/2026
|
||||
| Madison Avenue International LP | 6.6% | |||||
| Madison Avenue Partners, LP | 6.6% | |||||
| EMAI Management, LLC | 6.6% | |||||
| Madison Avenue GP, LLC | 6.6% | |||||
| Caraway Jackson Investments LLC | 6.6% | |||||
| Eli Samaha | 6.6% | |||||
|
CARGO Therapeutics, Inc.
13G/A
CRGX · 14179K101
|
0% |
11/14/2025
Event 9/30/2025
|
||||
| Madison Avenue Partners, LP | 0% | |||||
| Madison Avenue International LP | 0% | |||||
| EMAI Management, LLC | 0% | |||||
| Madison Avenue GP, LLC | 0% | |||||
| Caraway Jackson Investments LLC | 0% | |||||
| Eli Samaha | 0% | |||||
|
Sage Therapeutics, Inc.
13G/A
SAGE · 78667J108
|
0% |
11/14/2025
Event 9/30/2025
|
||||
| Madison Avenue Partners, LP | 0% | |||||
| Madison Avenue International LP | 0% | |||||
| EMAI Management, LLC | 0% | |||||
| Madison Avenue GP, LLC | 0% | |||||
| Caraway Jackson Investments LLC | 0% | |||||
| Eli Samaha | 0% | |||||
|
Ovid Therapeutics Inc.
13G/A
OVID · 690469101
|
4.0% |
2/14/2025
Event 12/31/2024
|
||||
| Madison Avenue Partners, LP | 4.0% | |||||
| Madison Avenue International LP | 4.0% | |||||
| EMAI Management, LLC | 4.0% | |||||
| Madison Avenue GP, LLC | 4.0% | |||||
| Caraway Jackson Investments LLC | 4.0% | |||||
| Eli Samaha | 4.0% | |||||
|
John Wiley & Sons, Inc.
13G/A
WLY · 968223206
|
4.95% |
2/14/2025
Event 12/31/2024
|
||||
| Madison Avenue Partners, LP | 4.95% | |||||
| Madison Avenue International LP | 4.95% | |||||
| EMAI Management, LLC | 4.95% | |||||
| Madison Avenue GP, LLC | 4.95% | |||||
| Caraway Jackson Investments LLC | 4.95% | |||||
| Eli Samaha | 4.95% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.